In the intricate landscape of peptide research, few molecules have commanded as much sustained scientific curiosity as CJC-1295. Originally developed to overcome the pharmacokinetic limitations of earlier growth hormone–releasing hormone (GHRH) analogues, this synthetic peptide has become a cornerstone in laboratory investigations exploring the pulsatile nature of the somatotropic axis. What sets CJC-1295 apart is…